Ep4 Receptor Agonist, Compositions And Methods Thereof

Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.


Claims

Information currently unavailable.

Owners (US)

Information currently unavailable.

IPC Classifications
Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Jul 19, 2011
  • Application: Apr 26, 2007
    US US 79604407 A
  • Priority: Apr 26, 2007
    US US 79604407 A
  • Priority: Mar 10, 2004
    US US 79725704 A
  • Priority: Mar 26, 2003
    US US 45770003 P

Download Citation


Sign in to the Lens

Feedback